Portfolio company
Accipiter Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
5 investors
Sectors
About
Accipiter Biosciences develops custom-engineered protein therapies using computational design to treat complex diseases like cancer and autoimmune disorders for the healthcare sector.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
UbiquiTx
This company develops a programmable protein modulation platform using artificial intelligence to create targeted therapies for pharmaceutical businesses and patients with complex diseases.
Outpace Bio
This biotechnology company develops custom protein-designed cell therapies to treat solid tumours and autoimmune diseases for patients and pharmaceutical partners.
Arpelos Biosciences
This biotechnology company develops multivalent therapeutics and biologics using protein engineering to treat various diseases for healthcare providers and pharmaceutical patients.
Harmonic Discovery
The company develops a machine learning platform to design multi-targeted kinase therapeutics for pharmaceutical firms and healthcare providers treating cancer and autoimmune diseases.
SynsoryBio
SynsoryBio develops protein therapeutics designed to sense specific disease markers and activate only at targeted tissues to treat cancer and autoimmune disorders.
Aperiam Bio
The company uses computer vision to design stable, high-performing proteins for customers in the cosmetics, therapeutics, and technical reagents sectors.
Aikium
This company develops artificial intelligence and synthetic biology platforms to design and screen protein therapeutic libraries for biotechnology and pharmaceutical partners.
DeepSeq.AI
DeepSeq.AI develops an artificial intelligence platform for protein drug discovery and biologics design for pharmaceutical and biotechnology companies.
